Author's Reply to “Was Another Consensus Document on Treating Exacerbations of Chronic Obstructive Pulmonary Disease Needed?”

García-Rodríguez, J.A.

doi:10.1016/S1579-2129(06)70104-5

array:22 ["pii" => "S1579212906701045" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)70104-5" "estado" => "S300" "fechaPublicacion" => "2004-06-01" "aid" => "70104" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "copyrightAnyo" => "2004" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2004;40:291-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1566 "formatos" => array:3 [ "EPUB" => 74 "HTML" => 985 "PDF" => 507 ] ] "itemAnterior" => array:18 [ "pii" => "S1579212906701033" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)70103-3" "estado" => "S300" "fechaPublicacion" => "2004-06-01" "aid" => "70103" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2004;40:290-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1632 "formatos" => array:3 [ "EPUB" => 59 "HTML" => 1050 "PDF" => 523 ] ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "Letters to the Editor" "titulo" => "Was Another Consensus Document on Treating Exacerbations of Chronic Obstructive Pulmonary Disease Needed?" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "290" "paginaFinal" => "291" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Llor Vilà, K. Naberan Toña" "autores" => array:2 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Llor Vilà" ] 1 => array:2 [ "nombre" => "K." "apellidos" => "Naberan Toña" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212906701033?idApp=UINPBA00003Z" "url" => "/15792129/0000004000000006/v1_201305150057/S1579212906701033/v1_201305150057/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "Letters to the Editor" "titulo" => "Author's Reply to “Was Another Consensus Document on Treating Exacerbations of Chronic Obstructive Pulmonary Disease Needed?”" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "291" "paginaFinal" => "292" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "J.A. García-Rodríguez" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J.A." "apellidos" => "García-Rodríguez" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "On behalf of the Consensus Group" ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "REFERENCES" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "NR Anthonisen" 1 => "J Manfreda" 2 => "PW Warren" 3 => "ES Hersfield" 4 => "GK Harding" 5 => "NA Nelson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1987" "volumen" => "106" "paginaInicial" => "196" "paginaFinal" => "204" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3492164" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Llor C, Mayer M. Recomendaciones en el uso de antimicrobianos en atención primaria. 3rd ed. Barcelona: 1999." ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F Sánchez" 1 => "J Mensa" 2 => "A Martínez" 3 => "E García" 4 => "F Marco" 5 => "J González" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/374846" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2003" "volumen" => "36" "paginaInicial" => "1239" "paginaFinal" => "1245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12746768" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae." "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "JR Lonks" 1 => "J Garau" 2 => "L Gómez" 3 => "M Xercavins" 4 => "A Ochoa de Echagen" 5 => "IF Gareen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/341978" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2002" "volumen" => "35" "paginaInicial" => "556" "paginaFinal" => "564" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12173129" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Andrews J, Honeybourne D, Khair O, et al. Penetration of telithromycin (HMR 3647) into bronchial mucosa (BM), epithelial lining fluid (ELF) and alveolar macrophages (AM) following multiple oral doses [resumé 658]. Toronto: Proceedings of 40th Interscience Conference on Antimicrobial agents and Chemotherapy, 2000." ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Aubier M, Aldons PM, Leak A, et al. Efficacy and tolerability of a 5-day course of a new ketolide antimicrobial, telithromycin (HMR 3647), for the treatment of acute exacerbations of chronic bronchitis in patients with COPD [resumé 2.241]. Toronto: Proceedings of 40th Interscience Conference on Antimicrobial agents and Chemotherapy, 2000." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000004000000006/v1_201305150057/S1579212906701045/v1_201305150057/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/15792129/0000004000000006/v1_201305150057/S1579212906701045/v1_201305150057/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212906701045?idApp=UINPBA00003Z"]

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and basic research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article